Review of phase I clinical studies with topotecan

Seminars in Oncology

Volumn 24, Issue 6 SUPPL. 20, 1997, Pages

  Rowinsky, E K ^a   Verweij, J ^a  

^a CTRC Institute for Drug Development   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CAMPTOTHECIN DERIVATIVE; DNA TOPOISOMERASE INHIBITOR; TOPOTECAN;

ANTINEOPLASTIC ACTIVITY; BONE MARROW SUPPRESSION; BREAST CANCER; CANCER PATIENT; CLINICAL TRIAL; COLON CANCER; DRUG USE; HUMAN; LUNG CANCER; OVARY CANCER; PHASE 1 CLINICAL TRIAL; PRIORITY JOURNAL; REVIEW; SOLID TUMOR;

EID: 0031473908     PISSN: 00937754     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (53)